Advisor Resource Council’s AbbVie ABBV Stock Holding History

Advisor Resource Council’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$984K	Buy	3,862 +244	+7%	+$52.5K	0.28%	72
2026 Q1	$787K	Buy	3,618 +37	+1%	+$8.21K	0.25%	82
2025 Q4	$808K	Buy	+3,581	New	+$816K	0.29%	79
2025 Q3	–	Sell	-1,356	Closed	-$252K	–	43
2025 Q2	$252K	Sell	1,356 -7,490	-85%	-$1.39M	0.1%	150
2025 Q1	$1.6M	Buy	+8,846	New	+$1.72M	0.13%	182
2024 Q4	–	Sell	-3,722	Closed	-$735K	–	71
2024 Q3	$735K	Buy	+3,722	New	+$695K	0.33%	76
2024 Q2	–	Sell	-5,640	Closed	-$878K	–	70
2024 Q1	$878K	Buy	5,640 +1,315	+30%	+$227K	0.37%	65
2023 Q4	$670K	Sell	4,325 -154	-3%	-$22.5K	0.08%	235
2023 Q3	$668K	Sell	4,479 -120	-3%	-$17.6K	0.34%	54
2023 Q2	$620K	Sell	4,599 -1,474	-24%	-$216K	0.28%	60
2023 Q1	$980K	Buy	6,073 +580	+11%	+$88.7K	0.25%	107
2022 Q4	$888K	Sell	5,493 -535	-9%	-$82K	0.43%	49
2022 Q3	$809K	Sell	6,028 -6,557	-52%	-$941K	0.55%	46
2022 Q2	$1.93M	Sell	12,585 -302	-2%	-$46.1K	0.18%	128
2022 Q1	$2.09M	Sell	12,887 -7,207	-36%	-$1.05M	0.63%	43
2021 Q4	$2.72M	Buy	20,094 +5,523	+38%	+$652K	0.21%	95
2021 Q3	$1.57M	Sell	14,571 -3,228	-18%	-$369K	0.48%	60
2021 Q2	$2M	Buy	+17,799	New	+$2M	0.21%	106

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisor Resource Council's ABBV Position: Q2 2026 in Review

Advisor Resource Council increased its AbbVie (ABBV) stake by 6.7% in Q2 2026, buying an estimated $52.5K and bringing the position to 3,862 shares worth $984K. The position accounts for 0.28% of the portfolio, ranked #72.

Advisor Resource Council first reported a position in ABBV in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.72M in Q4 2021. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Advisor Resource Council held 3,862 shares of AbbVie worth $984K as of Q2 2026.
Advisor Resource Council bought 244 AbbVie shares in Q2 2026, an estimated $52.5K.
AbbVie made up 0.28% of Advisor Resource Council's portfolio in Q2 2026, its #72 holding.
Advisor Resource Council first reported a position in AbbVie in Q2 2021 and has held it in 18 quarters since.
Advisor Resource Council's AbbVie position peaked at $2.72M in Q4 2021.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advisor Resource Council's 13F filing for Q2 2026, filed 28 Jul 2026.